Lupus Research Alliance Hails Approval of Aurinia's Lupkynis(TM) (voclosporin)

[In The News]

NEW YORK, Jan. 22, 2021 /PRNewswire/ -- The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals' LupkynisTM (voclosporin) as the first oral treatment developed specifically for adults with active...

View the full article